MoneyWorks4Me

Everest Organics informs about disclosure

19 Feb 2021 Evaluate
Everest Organics has informed that it has enclosed the disclosure received from the acquirer BK Advance Research, LLP, PAC of the Company in Form 29(2) under Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 and Form C under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..